JPRN-UMIN000010480RecruitingPhase 1
Phase I trial of biweekly Carboplatin plus nab-Paclitaxel with concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer - Phase I trial of biweekly CBDCA + nab-PTX +TRT for LA-NSCLC
Aomori Prefectural Central Hospital0 sites18 target enrollmentStarted: May 1, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Enrollment
- 18
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Patients with T3N1. 2) Superior vena cava syndrome. 3) Contralateral hilar lymph node metastasis, malignant plueral, pericardial effusion, carcinomatous lymphangiosis. 4) Active double cancer. 5) Active infections requiring systemic treatment. 6) Severe concurrent disease (Pulmonary fibrosis or interstitial pneumonia, renal failure, hepatic failure, cerebrovascular disease, ischemic heart disease requiring treatment, arrhythmia, cardiac infarction within 6 months before enrollment, hemorrhagic peptic ulcer, poorly controlled diabetes). 7) Grade 2 or higher peripheral neuropathy. 8) Positive HBs antigen and/or HCV antibody. 9) History of Severe drug allergies. 10) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy. 11) Physician concludes that the patient's participation in this trial is inappropriate.
Investigators
Similar Trials
Completed
Phase 2
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30
Completed
Not Applicable
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancerJPRN-UMIN000010324orth Japan Lung Cancer Study Group35
Completed
Phase 2
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000012025Osaka City General Hospital35
Completed
Not Applicable
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
Recruiting
Phase 1
Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2on-small-cell lung cancerJPRN-UMIN000014544Shizuoka cancer center33